JAPMA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jude, E. B.
Right arrow Articles by Boulton, A. J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jude, E. B.
Right arrow Articles by Boulton, A. J. M.
Journal of the American Podiatric Medical Association Volume 92 Number 7 381-383 2002
Copyright © 2002 American Podiatric Medical Association

Medical Treatment of Charcot’s Arthropathy

Edward B. Jude, MD, MRCP* and Andrew J. M. Boulton, MD, FRCP{dagger}

* Consultant Physician, Diabetes Centre, Tameside General Hospital, Fountain St, Ashton-Under-Lyne, Lancashire OL6 9RW, England.
{dagger} Professor, Department of Medicine, Manchester Royal Infirmary, Manchester, England.

Abstract

Charcot’s arthropathy is a devastating condition affecting diabetic patients with peripheral neuropathy, resulting in a foot at risk for ulceration and amputation. Early diagnosis is important for the institution of appropriate treatment, which may help prevent disease progression and foot deformity. This article discusses the pathogenesis and treatment options available for the disorder. (J Am Podiatr Med Assoc 92(7): 381-383, 2002)




This article has been cited by other articles:


Home page
 J. Am. Podiatr. Med. Assoc.Home page
M. S. Judge
Infection and Neuroarthropathy: The Utility of C-reactive Protein as a Screening Tool in the Charcot Foot
J Am Podiatr Med Assoc, January 1, 2008; 98(1): 1 - 6.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
R. Bem, A. Jirkovska, V. Fejfarova, J. Skibova, and E. B. Jude
Intranasal Calcitonin in the Treatment of Acute Charcot Neuroosteoarthropathy: A randomized controlled trial.
Diabetes Care, June 1, 2006; 29(6): 1392 - 1394.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
D. Pitocco, V. Ruotolo, S. Caputo, L. Mancini, C. M. Collina, A. Manto, P. Caradonna, and G. Ghirlanda
Six-Month Treatment With Alendronate in Acute Charcot Neuroarthropathy: A randomized controlled trial
Diabetes Care, May 1, 2005; 28(5): 1214 - 1215.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Podiatric Medical Association.